Trials / Completed
CompletedNCT01675609
Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects
A Single-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Eye Therapies, LLC · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of brimonidine tartrate 0.025% ophthalmic solution used four times daily in a population of adult and geriatric subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | 1 drop in each eye daily for up to 35 days |
| DRUG | Brimonidine tartrate 0.025% | 1 drop in each eye for up to 35 days |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2012-10-01
- First posted
- 2012-08-30
- Last updated
- 2014-07-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01675609. Inclusion in this directory is not an endorsement.